Novo Nordisk

Novo Nordisk Places $145 Billion Bet on Oxford University Diabetes Research Unit

Novo Nordisk Places $145 Billion Bet on Oxford University Diabetes Research Unit

Danish pharmaceutical giant Novo Nordisk has planned $145 billion investment in Oxford University’s diabetes research center. The money will be invested over a period of 10 years.

Drug May Lead to 6% Weight-loss in Type-2 Diabetics

Drug May Lead to 6% Weight-loss in Type-2 Diabetics

A clinical trial in Denmark has shed light on the fact that drug liraglutide can lead to weight loss in overweight or obese people with type-2 diabetes.

Novo Nordisk Celebrates 90 Years of Insulin Production

Novo Nordisk Celebrates 90 Years of Insulin Production

Novo Nordisk has been supplying insulin, thereby saving lives of a large number of diabetes patients, for many years now. As per a report, the time for the company to celebrate has now come.

FDA Approves Levemir Drug Further

FDA Approves Levemir Drug Further

A report has unveiled recently that a diabetes drug made by Danish drugmaker Novo Nordisk A/S has been further approved by the US Food and Drug Administration for small children.

Novo Nordisk Escalates Research Efforts for Curing Type 1 Diabetes

Novo Nordisk Escalates Research Efforts for Curing Type 1 Diabetes

While there is no doubt that Type 1 diabetes has affected millions of people around the world, a recent report confirmed that Danish drug company Novo Nordisk is making efforts in the direction of

Famous Chef Paula Deen, a Diabetic!

Famous Chef Paula Deen, a Diabetic!

A recent report has unveiled that Paula Deen, a famous celebrity chef, had kept her disease of diabetes under covers and kept on promoting sugar-rich foods.